cbdMD’s Post

📣 #HYPIEND partner, Dorota Komar, PhD, from Eurecat - Technology Centre held a talk about endocrine disrupting chemicals effects on epigenetic programming at the XXXIII Congress of the Sociedad Española de Nutrición - SEÑ 👉 The HYPIEND project was introduced as one of the ongoing European research projects on understanding and minimizing #EDCs effects. 🔬 Read the full article here 🔗 https://lnkd.in/dA3m6T3S

Published! Glad to have contributed to this comprehensive review on the hawthorn fruit (山楂）, and evaluated its effectiveness in treatment and potential to be developed into a medical food! 😁 https://lnkd.in/gG_H9QPn

Our second scientific paper on Quercetin LipoMicel has been published in the Journal of Evidence-based Complementary and Alternative Medicine: https://lnkd.in/eAMEhJnJ #quercetin #bioavailability #nhp #traditionalmedicine #phytochemistry

How did C15:0, the newest essential #fattyacid come to market? We embraced the #science, the skeptics, and above all, our determination to make a positive change in the world. Read more in our Q&A with NutraIngredients, out today!

Lambros Kromidas, M.S., PhD, will be attending the Happi & Nutraceuticals World Wellness Conference to speak about a one-day microbiome friendly efficacy study! “Our microbiota is an integral part of us that we can no longer ignore. I will show a simple way one’s topical products can impact the skin microbiota.” —Lambros Kromidas, M.S., Ph.D., Global Legal—Regulatory Affairs Liaison, Shiseido Are you attending? It's not too late to register: https://hubs.li/Q01-JB0n0

🔬 What were the top ten developments in biotic science in 2023? In our latest blog post, read about this year's highlights & trends as identified by ISAPP experts: - Increased recognition of biotics as a category - Advances in technologies for analyzing different sites in the digestive tract - And more! https://lnkd.in/dqKgpWeQ

OTC acetaminophen: responsible for 56,000 emergency department visits, 2,600 hospitalizations, and 500 deaths per year (NIH data) OTC alcohol: more than 178,000 deaths every year, played a role in at least 7.1% of emergency department visits (NIH data) OTC tobacco: more than 480,000 deaths every year or about 1 in 5 deaths (CDC data) OTC aspirin: A numerically higher rate of the secondary end point of death from any cause was observed with aspirin than with placebo. (NEJM 2018) OTC PPI (acid reflux drugs): Pooled mortality rate higher among PPI users compared with non‐PPI users; In Charlot et al, 2011, mortality increased during 1‐year follow‐up in people taking PPIs (NIH data) OTC NSAIDs: "From the first day of use, all NSAIDs increase the risk of gastrointestinal (GI) bleeding, myocardial infarction, & stroke." (NIH data) CBD: No deaths; Overdose = good night's sleep; Proven properties: anticonvulsant, anti-cancer, anti-anxiety, antidepressant, anti-inflammatory, anti-psychotic, neuroprotectant, analgesic, antioxidant, anti-addiction, cardioprotective, hepatoprotective, reduces chemo-induced nephropathy and neuropathy, stabilizes blood sugars. When does the stigma end?

Could n-acetyl cysteine, a drug that costs around $35 a month, prevent deaths from PF and ILD? That’s what researchers are investigating right now! In an interesting new article with Drs. Imre Noth and Melina Kibbe of the University of Virginia, they explain what their clinical trials have uncovered about this exciting new research. https://lnkd.in/gpGmWN64

I'm delighted to share another research article that has recently been published online.  "The impact of differently structured starch gels on the gastrointestinal fate of a curcumin-containing Nanoemulsion". The key findings of this study are: 1. The waxy corn starch gel disintegrated and emptied much slower than native and high amylose corn starch gels under dynamic gastric conditions. 2. Despite the differences in the gels' amylose content, glucose release was similar due to the differences in the emptying rate of total solids from the gastric simulator.   3. These differences in the digestion behavior of the gels led to a change in the rate of free fatty acid release and the delivery of curcumin into the intestinal digestion phase.  Riddet Institute https://lnkd.in/gzCEjU2x

As the DOI is now active I am happy to share that the advance copy of the 6th paper of my PhD is now out in Beneficial Microbes. In this study we explored the effect of the food matrix on the prebiotic efficacy of inulin-type fructans using a 10-day four-arm parallel randomised trial. Inulin was either supplemented in pure form or fortified into shortbread, milk chocolate or rice milk. The main takeaway from this trial is that the food matrix does not appear to impact on the bifidogenic effect of inulin-type fructans with similar increases seen across all four interventions. The trial was conducted during lockdown when volunteers were not allowed to visit campus or leave their houses. So, I ended up cycling 4500 km for this trial dropping off food products/supplements and collecting samples. If that is not dedication and passion towards advancing science I don't know what is. Unfortunately the paper is not open access so you will have to be subscribed to Beneficial Microbes to gain access: https://lnkd.in/ecjgCkaF I do still have a couple of authors copies I am allowed to share so drop me an email and I will see what I can do.